News & Events
China seeks commercial planting of biotech rice soon
International Service for the Acquisition of Agri-biotech Applications (ISAAA)
After extensive field and pre-commercial trials in the past few years, China is expected to seek approval for the commercial production of its first biotech rice varieties within the year. These varieties are resistant to the stem borer pest, a major problem across Asia, including China, where rice is widely planted. “The signals are clear for their possible commercialization,” says Dr. Randy Hautea, global coordinator of the International Service for the Acquisition of Agri-biotech Applications (ISAAA).
Hautea quoted reports from China that field-testing of rice varieties in the provinces of Hubei an Fujian yield increases of around 4 percent (4%) to 8 percent (8%) and pesticide reduction of around 80 percent (80%). This translates to an overall increase in net income by US$80-US$100 per hectare.